Geri
VIA Pharmaceuticals Inc (VIAP) Fiyatı
VIAP Hisse Senedi Fiyat Grafiği
VIAP Kazanmak
VIA Pharmaceuticals Inc
$0
0%
$0
Kapanışta: Feb 09, 16:00:00 GMT-5
$0
0%
$0
Ön Piyasa: Feb 10, 04:50:15 GMT-5
Henüz Veri YokEarnings FAQ
VIAP'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
VIA Pharmaceuticals Inc VIAP'ün son çeyrekteki geliri nasıl performans gösterdi?
VIA Pharmaceuticals Inc'in gelir tahmini nedir?
VIA Pharmaceuticals Inc'in kazanç kalite puanı nedir?
VIA Pharmaceuticals Inc kazançlarını ne zaman rapor eder?
VIA Pharmaceuticals Inc'in beklenen kazançları nelerdir?
VIA Pharmaceuticals Inc kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.0005
Açılış fiyatı
$0.0005
Günün Aralığı
$0.0005 - $0.0005
52 haftalık aralık
$0 - $0.0005
İşlem hacmi
700
Ort.Hacim
0
EPS (TTM)
-0.47
Dividend yield
--
Piyasa Değeri
$10.2K
VIAP nedir?
VIA Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of compounds for the treatment of cardiovascular diseases. The company is headquartered in San Francisco, California and currently employs 6 full-time employees. The company went IPO on 2000-04-18. The Company’s lead compound, VIA-2291, targets an unmet medical need of reducing atherosclerotic plaque inflammation, which is an underlying cause of atherosclerosis and its complications. Atherosclerosis is a cardiovascular disease that results from chronic inflammation and the build-up of plaque in arterial blood vessel walls. The Company’s clinical development strategy integrates several technologies to provide clinical proof-of-concept, as early as possible in the clinical development process. These technologies include the measurement of biomarkers, medical imaging of the coronary and carotid vessel walls to evaluate the plaque characteristics, and atherosclerotic plaque bioassays.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved